Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Onco.com, dedicated...

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-09-26T16:54:01+05:30  |  Updated On 14 Aug 2021 11:35 AM IST

    Bengaluru,: Onco.com, India's only internet aggregator for cancer care, announced completion of $7 million in series A funding by Accel, Chiratae Venture (earlier known as IDG Ventures) and Dream Incubator.


    Onco.com is an internet aggregator in healthcare specializing in cancer care. Through its network of world class oncologists, Onco.com provides accurate and personalized scientific advice to cancer patients at every stage of their journey. It manages their care end-to-end by connecting them with the relevant treatment centres, doctors and labs and provides solutions to their questions and concerns throughout their treatment journey. Onco.com envisions becoming a one stop platform for all cancer related needs for the patients and their family members.


    The company aims to expand its customer base and scale up the operations globally. Currently over 30,000 patients from 18 countries actively use the platform. Onco.com will utilize the funds to build team, scale operations and expand customer outreach within India and internationally.


    Commenting on the Series A funding, Ms. Rashie Jain, CEO and Co-founder, Onco.com, said, "We are solving a very critical problem, that of "information gap" that every cancer patient and their family experiences. There are 3 million cancer patients getting treated in India alone and around 7 million cancer patients across Middle-east, Africa and Asia where our services are available presently. A significant number of patients struggle to get the right treatment advice or find the right doctors/hospitals that could eventually affect their outcomes and presently there is no credible source of information that guides the patients to right treatment plan, doctors and hospitals and this creates a state of confusion and despair. With Onco.com, we are focused on building this cancer ecosystem that patients can tap into anytime in their treatment journey. "


    Dr. Amit Jotwani, Co-founder of Onco.com and Chief of Medical Affairs says, "Every year around 1.5 million new cases of cancer are reported in India and as more and more advancements come in the field of cancer, it will become critical for patients to be empowered with more personalized treatment guidance so that they can embark on this journey with confidence. With our platform we aim to enable the patients with the best treatment options and critical medical advisory through our multidisciplinary approach and network of cancer type specific expert oncologists and hospitals to ensure that every patient has the best chance at recovery."


    Mr. Barath Shankar Subramanian, Partner, Accel India said, "It has been an incredibly fulfilling journey to see Onco.com grow from a concept to a clinically recognized technology cancer care platform that offers full stack support to cancer patients and caregivers in India and emerging markets. Given the hugely increasing cancer disease burden and severely skewed oncologists-to-patient ratio in the country, we believe that there is tremendous work to be done in cancer care delivery. It is clear to us that the best way for effective healthcare to progress is by building awareness, collaborations and communities on a patient-centric and network aggregated business model, which onco.com does holistically."


    Mr. Ranjith Menon, Executive Director, Chiratae Ventures said "Cancer is a global challenge. India alone adds more than a million patients every year. We are excited to see Onco.com developing into a vertical platform that brings all the various stakeholders like patients, clinicians, care providers, and diagnostics."


    Mr. Munehiko Eto, MD of Dream Incubator India said, "It is my great pleasure to support Onco's mission which tries to provider better cancer treatment in India and other emerging economies by empowering patients and their families as well as solving information asymmetry. I strongly feel that Onco.com is not only a technology company but a healthcare company. Its team extends warm hospitality and possesses positive attitude while taking on a big responsibility as a heath-tech start-up. DI has extensive expertise and network in the healthcare space in Japan and SEA and will support Onco.com in international expansion. In India, we have made 20+ investments in the space of Health, Finance, Media & Entertainment and other areas. This is our 5th investment in health space in India."


    The company currently has a network of over 1500 oncologists from India and United States of America; 500+ treatment centers (including specialty hospitals and chemo infusion centers) across India and pan-India network of diagnostic labs with cutting edge technology. Onco.com handles around 10,000 unique cancer cases month on month across different geographies. Onco.com also offers complimentary treatment advice to children under 14 years. Until now, the company has assisted over 100 children with cancer.

    Accel PartnersBengalurucancerCEOChief of Medical AffairsChiratae Venturesco-founderDr. Amit JotwaniDream IncubatorExecutive DirectorfundMDMedical Affairsmedical fundMr Barath Shankar SubramanianMr Munehiko EtoMr Ranjith MenonMs Rashie JainOnco.comOncologistsPatientpioneer cancerSeries A funding
    Source : SELF

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok